MIRA
INFORM REPORT
|
Report Date : |
01.06.2007 |
IDENTIFICATION DETAILS
|
Name : |
SUAN HONG TRADING CO LTD |
|
|
|
|
Registered Office : |
1FL, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2006 |
|
|
|
|
Date of Incorporation : |
December 28, 1993 |
|
|
|
|
Com. Reg. No.: |
84500155 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Importing wide range of chemical raw materials for western
pharmaceuticals. Local distribution and sales. |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average/normal. |
Small |
|
Maximum Credit Limit : |
Up To USD 10,000 |
|
|
|
|
Status : |
Small Company |
|
|
|
|
Payment Behaviour : |
Usually correct |
|
|
|
|
Litigation : |
Clear |
name & address
SUAN HONG TRADING CO LTD
1FL,
TEL: 886-2-23365826
FAX: 886-2-23085899
EXECUTIVE SUMMARY
INCORPORATION DATE :
DECEMBER 28, 1993
REGISTRATION NO. :
84500155
LEGAL FORM :
PRIVATE LIMITED COMPANY
CHIEF EXECUTIVE :
MR. TEH-SHENG CHAN (CHAIRMAN)
STAFF STRENGTH :
7
CAPITAL :
US$ 195,724
BUSINESS LINE :
IMPORTER
TURNOVER :
US$564,087.06 (AS OF DEC. 31, 2006)
EQUITIES :
N/A (AS OF DEC. 31, 2006)
PAYMENT :
AVERAGE
RECOMM.
MARKET CONDITION :
COMPETITIVE
FINANCIAL CONDITION :
STABLE
OPERATIONAL TREND : STEADY
GENERAL REPUTATION :
AVERAGE
EXCHANGE RATE :
TWD 33.11307 = US$1 AS OF 2007-6-1
Adopted abbreviations:
ANS - amount not stated
NS - not stated
SC - subject company (the company inquired by you)
NA - not available
M - million
TWD –
*Company Registration*
===================
License number : 84500155
Date issued : 28
December, 1993
Issuing authority : Ministry of
Economic Affairs (MOEA)
Legal form : Private
Company
*Office & Facilities*
================
Size : 97 sq.
meters
Location : Central
Business District (CBD)
Property status : Rented
Type of building :
Semi-residential building
*Corporate & Organization Structure*
=============================
A small-sized specialized company operated and managed by the principal
owner.
*Factories, Size & Locations*
=======================
The company is a trading house focused on importation of overseas
products, and maintains no manufacturing facilities.
*Reputation*
==========
Reference checking for the purpose of establishing the firm's reputation
within the respective industry failed to reveal any negative information.
E-mail: suanhongtrading@hotmail.com
For the past two years there is no record of litigation.
*Major Shareholders*
=================
Shareholders' Name
% of Shares
---------------------------
----------------
Mr. Teh-sheng Chan
99.00
Undisclosed shareholder/s
1.00
Management: Mr. Teh-sheng Chan, General Manager
Name Nationality
Job Description
Mr. Teh-sheng Chan Taiwanese General Manager
*Key Personnel*
=============
Mr. Teh-sheng Chan
Founder : Sole
Founder
Resident status :
Work experience : More than 10 years
Responsibility : Handles the
daily operation of the firm including all financial and legal matters.
*Main Products & Services*
=====================
Specializes in the following areas of work:
1. Importing wide range of chemical raw materials for western
pharmaceuticals.
2. Local distribution and sales.
Products: Acetaminophen
Ampicillin
sodium
Brompheniramine
maleate
Chemical raw
materials
Diphenhydramine
hydrochloride
*Payment Terms*
==============
Sales
-------
Local : 30-90 days credit
Purchases
--------------
Local : 30-90 days credit
Import : Letter of Credit (L/C)
Open Account (D/A)
with settlement using Telegraphic Transfer (T/T)
*Competitors*
===========
The following locally based firms supply similar range of products :
- SOUTHERN ACE TRADING CORP
- CHAIJARL BIOTECHNOLOGY CORP
- GOLDMONT INT'L CORP
- GREAT UNITED STRONG ENTERPRISE CO LTD
- GREMONT CHEMICAL CO LTD
*Local Distribution Network*
=======================
100% of the annual turnover is attributed to local sales.
*Export Markets*
==============
There is no record of export since the prime focus of the firm's
activity is concentrated on local sales only.
*Overseas Suppliers*
=================
Major overseas suppliers include:
Suppliers' Name
Country Products
---------------------
----------- ------------
- DISHMAN PHARMACEUTICALS & CHEMICALS LTD India Lidocaine hydrochloride, Lidocaine
(base)
- SUPRIYA CHEMICALS India Brompheniramine maleate,
Chlorpheniramine maleate,
Pyrilamine
maleate
- AMSAL CHEMICAL PVT LTD
- SHIJIAZHUANG PHARMA GROUP ZHONGNUO
PHARMACEUTICAL (
Hydrochloride
- HEBEI HUARONG PHARMACEUTICAL CO LTD
-
- XIANNING JINGHUI PHARMACEUTICAL
CO LTD
-
CO LTD
- BEIJING TAIYANG PHARMACEUTICAL INSUSTRY China Diphenhydramine hydrochloride,
CO LTD
Chlorpheniramine Maleate,
Metoclopramide HCL
-
CO LTD Guaiacolsulfonate
- YANGZHOU PHARMACEAUTICAL CO LTD
- TIANJIN TIANYAO PHARMACEUTICALS CO LTD
- PANJIN XINGHAI PHARMACEUTICAL CO LTD
-
CO LTD
- HENAN LIHUA PHARMACEUTICAL CO LTD
SC is not known to have any subsidiary at
present.
PAYMENT RATING : 3 OBTAINED SCORES : 57
|
Implication |
Implications |
|
|
1 |
Scores 85–100 |
Excellent |
|
2 |
Scores 75 – 84 |
Above Average |
|
3 |
Scores 50 – 74 |
Average |
|
4 |
Scores 35 – 49 |
Fair |
|
5 |
Scores 15 – 34 |
Below Average |
|
6 |
Scores 01 – 14 |
Poor |
|
NR |
No Data |
No Data |
The rating indicates the
payment pattern of SC based upon our Payment Database, comments from suppliers
of SC, information from banks (if available), as well as industrial sources.
Dealings on open terms may be possible for SMALL
amounts depending on individual judgement experience.
*Bank Details*
============
Bank name : CHANG HWA COMMERCIAL BANK LTD
Branch :
Swiftcode : CCBCTWTP
As a private limited company with a paid-up capital of less than USD 6
million, there is no legal requirement according to
*Financial Summary (Currency:
==============================
Year Sales Assets Net Income
2006 $564,087.06 $190,447.40 $105,804.11
*Int´l Trade Activity (Currency:
===============================
Year Imports Exports Total
2004 $149,000.00 $0.00 $149,000.00
2005 $238,000.00 $37,100.00 $275,100.00
2006 $361,000.00 $0.00 $361,000.00
Over the past 14 years, SC has made a stable growth with satisfactory
profit. It is considered a credit line up to USD 10,000 appears to be within
SC’s capacities.
Attached:
trade references
SIC PRODUCT CLASSIFICATION & ACTIVITY
Activity Code Product/Service Description
Importing 2800 Chemicals
and Allied Products
Importing 2834 Pharmaceutical
preparations
Importing 2899 Chemical
preparations,
Trading 2800 Chemicals
and Allied Products
Trading 2834 Pharmaceutical
preparations
Trading 2899 Chemical
preparations,
HARMONIZED PRODUCT CLASSIFICATION & ACTIVITY
Activity Code Product/Service Description
Importing 2909490500 Guaifenesin
Importing 2922191000 Diphenhydramine;
and tamoxifen citrate
Importing 2924 Carboxyamide-function
comp; amide-function com etc
Importing 2924293910 Acetaminophen
Importing 2924296210 Acetaminophen
Importing 2935004300 Chlorothiazide;
chloropropamide; hydrochlorothiazide and tolbutamide
Importing 2937210000 Cortisone,
hydrocortisone, prednisone and prednisolone
Importing 2937210040 Prednisolone
Importing 2939300000 Caffeine
and its salts
Importing 2941101000 Ampicillin
and its salts
DETAILED PRODUCT CLASSIFICATION & ACTIVITY
Activity Product/Service Description
Importing Hydrochlorothiazide
Importing Isoniazid
Importing Metoclopramide HCl
Importing Norfloxacin
Importing Ranitidine HCL
Importing Pyrilamine maleate
Importing Pyridoxine hydrochloride (VB6)
Importing Prednisolone
Importing Potassium
guaiacolsulfonate
Importing Piracetam
INTERNATIONAL TRADE : ACTIVITY & MARKETS
Importing from
Importing from
Importing from
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems comparatively
below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)